HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


'Close To A Perfect Quarter': E.l.f.'s Retail Partners Adding Shelf Space For Brand As Growth Streak Continues

Executive Summary

E.l.f. Beauty, Inc. says retailer CVS will more than double its shelf space in US stores in spring 2024, while Walmart will provide more space for the e.l.f. brand this summer. In a 6 February earnings report, the Oakland, Calif.-based firm reported its sales jumped 86% in the fiscal third quarter to $270.9m.

You may also be interested in...

Super Bowl LVIII: L’Oreal’s NYX To Kick Off First Ad; Dove Returns With Body Positivity Message; More

L’Oreal’s NYX Professional will make its debut alongside rapper Cardi B at Super Bowl LVIII in Las Vegas on 11 February. Unilever’s Dove for women returns to the Big Game after 18 years, e.l.f. Beauty will take the field for the second year in a row, and P&G revives its ‘Battle of the Paddles.’

Cosmetics News: Natura Sells The Body Shop; e.l.f. Launches Roblox Experience; DIY Nailbot STEM Kit; More

Natura says its sale of The Body Shop to international private equity group Aurelius – following its divestiture of Aesop to L’Oreal in a deal that closed in August – is another step toward simplifying operations and refocusing on strategic priorities. More cosmetics news.

E.l.f. Eyes Becoming Top Three Cosmetic Brand In Canada, UK As Non-US Sales Soar 157%

E.l.f. Beauty ranks fourth among cosmetic brands in Canada with 7% market share and number six in the UK with 5% share as its non-US sales soar 157% in its latest quarter.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts